|
Vaccine Detail
Japanese encephalitis virus DNA vaccine encoding NS1 (pUSK-NS1) |
Vaccine Information |
- Vaccine Name: Japanese encephalitis virus DNA vaccine encoding NS1 (pUSK-NS1)
- Target Pathogen: Japanese encephalitis virus
- Target Disease: Japanese encephalitis
- Vaccine Ontology ID: VO_0011500
- Type: DNA vaccine
- Status: Research
- Antigen: Japanese encephalitis virus NS1
- NS1
gene engineering:
- Type: DNA vaccine construction
- Description: NS1 gene of Japanese encephalitis virus (JEV) SA14-14-2 strain was produced by reverse transcriptase-mediated PCR (RT-PCR) and was cloned into vector pUSK to form recombinant plasmid (designed as pUSK-NS1) (Xu et al., 2004).
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0005055
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Mouse Response
- Host Strain: BALB/c
- Vaccination Protocol: Ten 6-week-old Balb/c mice and eight 2-days old piglets were immunized with 5.0 log10pfu of the TK−/gG−/NS1+ mutant, while another equal number of animal in control groups with PBS (Xu et al., 2004).
- Challenge Protocol: The challenge was performed with PRV Ea strain at a concentration of 6.5 log10pfu (LD50=10−4.5) at day 7 for mice and day 14 for piglets post-vaccination (Xu et al., 2004).
- Efficacy: Balb/c mice and swine vaccinated with TK(-)/gG(-)/NS1(+) expressing NS1 protein of JEV could confer protective immunity against lethal challenge of the virulent PRV Ea strain and develop a good humoral and cellular immune response against JEV (Xu et al., 2004).
|
References |
Xu et al., 2004: Xu G, Xu X, Li Z, He Q, Wu B, Sun S, Chen H. Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity. Vaccine. 2004; 22(15-16); 1846-1853. [PubMed: 15121294].
|
|